PARP Inhibitor Tested in Cancer Patients Might Treat ALS, Study Suggests
Medicines used for ovarian and breast cancer, called PARP inhibitors, might be repurposed to treat people with amyotrophic lateral sclerosis (ALS),…
Articles by Janet Stewart, MSc
#AAN2018 — Anxiety and Depression Best Predict Caregiver Burden in ALS, Study Finds
Anxiety and depression were found to be associated with caregiver burden in people caring for amyotrophic lateral sclerosis (ALS)…
Extension of US Law Ensures Funding of Speech-Generating Devices for ALS Patients
The United States has enacted legislation to ensure permanent funding of speech-generating devices that allow people with degenerative diseases such…
Uric Acid Levels in Blood Associated with Lower Risk of Death in ALS Patients, Study Finds
The higher the levels of uric acid in the blood of amyotrophic lateral sclerosis (ALS) patients, the lower…
Protein Called NAIP Seen as Potential ALS Disease Marker, Study Finds
A protein called neuronal apoptosis inhibitor protein (NAIP) is a potential disease marker and predictor of outcomes…
Study Links Immune Cell Numbers to Progression of ALS
Changes in the numbers of immune cells in the blood are associated with the progression of ALS, a study reports.
Researchers Identify Novel Genes that Regulate Muscle Stimulation and Regeneration in ALS
Levels of some microRNAs (MIRs) regulating re-innervation and muscle regeneration among amyotrophic lateral sclerosis (ALS) patients, while others are lower,…
Mice with ALS-like Disease Function Better and Live Longer When Protein Receptor’s Activity Is Reduced
Researchers have slowed the progression of an ALS-like disease in mice, and prolonged their lives, by reducing the activity of…
Mutation That Interferes with Genetic Instructions May Cause Hereditary ALS, Study Reports
Harvard Medical School researchers have discovered how a mutation of the C9ORF72 gene causes the changes in energy production and…
Insilico Medicine to Use Artificial Intelligence Platform to Discover New ALS Therapies
Insilico Medicine has launched ALS.AI, a drug discovery platform for new amyotrophic lateral sclerosis (ALS) treatments. It uses a…